Summary of suggested
mechanisms involved in the cardiovascular
improvement in gestational calorie-restricted animals, associated
with high-esterified pectin (HEP) chronic supplementation. HEP supplementation
promotes the modulation of the gut microbiota by favoring the increase
in the relative abundance of beneficial species. The changes may indirectly
impact critical organs, such as the heart and the liver, modulating
gene expression and increasing FGF21 circulating levels. Although
the liver is the main productor of FGF21, from our results we cannot
distinguish whether the elevated blood levels are caused by increased
hepatic secretion or by other tissue/s. FGF21, via its specific receptor
FGFR1 and co-receptor β-Klotho, might be partly responsible
for the improvements observed in the heart, such as the increase in
lipid oxidation capacity and in Nppa expression,
which in turn would improve blood pressure. Overall, HEP supplementation
reverses the increased cardiovascular risk factors caused by gestational
calorie restriction and allows the recovery, or even improvement,
of metabolic flexibility.